New investor Credit Suisse Asset Management led the round and all existing preferred equity investors participated. All proceeds will help the company’s sales and marketing infrastructure grow.
Lanx’s device portfolio focuses on minimally invasive spine fusion solutions throughout the U.S., Mexico and Europe.
More Articles on Supply Chain:
A Model for Clinical, Financial Success in Orthopedics
MAKO Surgical Reports 26% Q1 Revenue Increase, MAKOplasty Surgeries Up 30%
Globus Medical Launches New Spinal Surgery System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
